Clinical Trial Details


Research Study Summary

New Onset Type 1 Diabetes: Role of Exenatide


The main purpose of this study is to see if the study medication Byetta improves after meal blood sugars in kids and adults with newly diagnosed Type 1 Diabetes. We will also compare how quickly food leaves the stomach in healthy controls when compared to the kids with diabetes getting the medication during the study. Study includes 4 outpatient visits over a 4-5 month period for kids with diabetes. Kids with diabetes will be compensated to a total of 570 dollars.

Patient Inclusion Criteria:

  • Between 12 and 18 years of age
  • Diagnosed with Type 1 Diabetes within the past 3 months

Patient Exclusion Criteria:

  • Younger than 12 years of age
  • Older than 18 years of age
  • Have not been diagnosed with Type 1 Diabetes

To Learn more

CW ID: 180695
Date Last Changed: October 16, 2014

Clinical Trial Snapshot

Both Male and Female
12 to 18 Years
Overall Status
5 Months
Facility Type
Up to $570


Ranjitha Katikaneni, Jeniece Trast
The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
Montefiore Medical Center
Division of Pediatric Endocrinology
111 East 210th Street
Bronx, NY 10467
Phone: (718) 741-2195; (718) 920-6191

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.